HUMAWのROE（自己資本利益率）は？

HUMACYTE INCのROEは-839.56%です。

HUMAWの配当利回りは？

HUMACYTE INCの配当利回りは0.00%です。

HUMAWの品質スコア（Quality Score）は？

当社のAIはHUMAWの総合財務品質を100点中38点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。

HUMAWは今が買い時ですか？

当社AIのタイミングスコアは100点中0点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。

HUMAW (NASDAQ) 株価分析 | HUMACYTE INC

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-03-31)

HUMAW AI Analysis Summary

Our AI summary for HUMAW: HUMACYTE INC (NASDAQ). The stock currently trades at a P/E of 0.00, ROE of -839.56%, a dividend yield of 0.00%. Its financial Quality Score stands at 38/100 — fundamentals below the market average. The AI Timing Score is 0/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

HUMAW

HUMACYTE INC

US:NASDAQ STOCK News 99

USD 0.01

0.00 (11.11%) Day Change

Watchlist Portfolio Compare Chart

3.29

D/E

-839.6%

ROE

-88.3%

ROA

0.00%

Div Yield

HUMACYTE INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 0.01 Price 0.00 (11.11%) Day Change	NEWS SCORE: 99

HUMAW, ファンダメンタルスコアはnot good ( ファンダメンタル = 38) そしてテクニカルスコアは ...(Sign In to See)...

Loading chart...

38 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROEが低い
ROAが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...

Deepscope 分析

45%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	99
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	0.01
PBV / Sector	N/A / N/A
Earning Per Share	N/A

PE / Sector	N/A / N/A
PEG or PE/Growth / Sector	N/A / N/A
Average 1M Daily Value	350.046360000000
Average 1W Daily Value	1192.437880000000

Timing Factors

57%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

37%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ポイントになる統計

43%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-4,840.82 / N/A
NPM Average (%) / Sector	-2,536.31 / N/A
NPM Change Average (%) / Sector	N/A / N/A
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-88.27 / N/A
ROA Average (%) / Sector	-64.69 / N/A
ROA Change Average (%) / Sector	371.02 / N/A GREAT
ROE (%) / Sector	-839.56 / N/A
ROE Average (%) / Sector	-539.72 / N/A
ROE Change Average (%) / Sector	1,788.98 / N/A
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

配当

Dividend (%) / Sector	N/A / N/A
Dividend Average (%) / Sector	N/A / N/A
Dividend Change Average (%) / Sector	N/A / N/A

登録情報

Analyze Date	2026-08-01 07:59:58
Symbol	HUMAW
Name	HUMACYTE INC
Sector	N/A
Market	NASDAQ
Listed Shares	0.00
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	N/A / N/A

ニュース

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 2525 East North Carolina Highway 54, Durham, NC, United States, 27713

Phone: 919 313 9633

Website: https://www.humacyte.com

Employees: 184

Sector: -

Description: Humacyte, Inc., together with its subsidiaries, engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs) to be implanted into patient without inducing a foreign body response or leading to immune rejection. It is developing a portfolio of HAVs, which would target the vascular repair, reconstruction, and replacement market, including vascular trauma; arteriovenous access for hemodialysis; peripheral arterial disease; pediatric heart surgery; and coronary artery bypass grafting, as well as for the delivery of cellular therapy, including pancreatic islet cell transplantation to treat Type 1 diabetes. Humacyte, Inc. was founded in 2004 and is headquartered in Durham, North Carolina.